Mandible Matrix Necrosis in Beagle Dogs After 3 Years of Daily Oral Bisphosphonate Treatment

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 5, 2008, Pages 987-994

  Allen, Matthew R ^a   Burr, David B ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE LESION; BONE NECROSIS; BONE TURNOVER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOG; FEMALE; JAW DISEASE; MORPHOMETRICS; MOUTH CAVITY; NONHUMAN; OSSIFICATION; PAGET BONE DISEASE; POSTMENOPAUSE OSTEOPOROSIS;

ADMINISTRATION, ORAL; ALENDRONATE; ANALYSIS OF VARIANCE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE MATRIX; BONE REMODELING; DOGS; FEMALE; MANDIBULAR DISEASES; OSTEONECROSIS; STATISTICS, NONPARAMETRIC;

EID: 42149112850     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.01.038     Document Type: Article

References (37)

1. Enlow D.H. Functions of the Haversian system. Am J Anat 110 (1962) 269
2. Enlow D.H. Osteocyte necrosis in normal bone. J Dent Res 45 (1966) 213
3. Frost H.M. In vivo osteocyte death. J Bone Joint Surg Am 42A (1960) 138
4. Dunstan C.R., Somers N.M., and Evans R.A. Osteocyte death and hip fracture. Calcif Tissue Int 53 suppl 1 (1993) S113
5. Migliorati C.A., Casiglia J., Epstein J., et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine position paper. J Am Dent Assoc 136 (2005) 1658
6. Ruggiero S.L., Mehrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527
7. Bilezikian J.P. Osteonecrosis of the jaw-Do bisphosphonates pose a risk?. N Engl J Med 355 (2006) 2278
8. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115
9. Shane E., Goldring S., Christakos S., et al. Osteonecrosis of the jaw: More research needed. J Bone Miner Res 21 (2006) 1503
10. National Osteoporosis Foundation. Osteonecrosis of the jaw (ONJ). http://www.nof.org/patientinfo/osteonecrosis.htm Accessed March 3, 2008
11. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations. J Am Dent Assoc 137 (2006) 1144
12. Khosla S., Burr D., Cauley J., et al. Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22 (2007) 1479
13. Kolata G. Drug for Bones Is Newly Linked to Jaw Disease (2006), The New York Times, New York
14. Woo S.B., Hellstein J.W., and Kalmar J.R. Systematic review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753
15. Lacy M.Q., Dispenzieri A., Gertz M.A., et al. Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc 81 (2006) 1047
16. Kuehn B.M. Reports of adverse events from bone drugs prompt caution. JAMA 295 (2006) 2833
17. Mavrokokki T., Cheng A., Stein B., et al. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65 (2007) 415
18. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 433
19. Huja S.S., Fernandez S.A., Hill K.J., et al. Remodeling dynamics in the alveolar process in skeletally mature dogs. Anat Rec A Discov Mol Cell Evol Biol 288 (2006) 1243
20. Garetto L.P., and Tricker N.D. Remodeling of bone surrounding the implant interface. In: Garetto L.P., Turner C.H., Duncan R.L., et al. (Eds). Bridging the Gap Between Dental and Orthopaedic Implants. Proceedings of the 3rd Annual Indiana Conference (1998) Indianapolis, IN
21. Burr D.B., and Stafford T. Validity of the bulk-staining technique to separate artifactual from in vivo bone microdamage. Clin Orthop Relat Res Nov (1990) 305
22. Frost H.M. Micropetrosis. J Bone Joint Surg Am 42-A (1960) 144
23. Allen M.R., Iwata K., Phipps R., et al. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 39 (2006) 872
24. Jaworski Z., and Lok E. The rate of osteoclastic bone erosion in haversian remodeling sites of adult dog's rib. Calcif Tissue Res 10 (1972) 103
25. Bentolila V., Boyce T.M., Fyhrie D.P., et al. Intracortical remodeling in adult rat long bones after fatigue loading. Bone 23 (1998) 275
26. Parfitt A., Drezner M., Glorieux F., et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2 (1987) 595
27. Plotkin L.I., Weinstein R.S., Parfitt A.M., et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104 (1999) 1363
28. Follet H., Li J., Phipps R.J., et al. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. Bone 40 (2007) 1172
29. Correia Vde F., Caldeira C.L., and Marques M.M. Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts. Dent Traumatol 22 (2006) 312
30. Moreira M.S., Katayama E., Bombana A.C., et al. Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. A pilot study. Dent Traumatol 21 (2005) 329
31. King L.E., Grynpas M.D., Tomlinson G., et al. Pamidronate content and turnover in sternum, vertebral body, and iliac bones of dogs. Bone 20 (1997) 405
32. Komatsubara S., Mori S., Mashiba T., et al. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res 19 (2004) 999
33. Zavras A.I., and Zhu S. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: Is it osteonecrosis?. J Oral Maxillofac Surg 64 (2006) 917
34. Migliorati C.A., Schubert M.M., Peterson D.E., et al. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive cancer therapy. Cancer 104 (2005) 83
35. Garetto L.P., Chen J., Parr J.A., et al. Remodeling dynamics of bone supporting rigidly fixed titanium implants: A histomorphometric comparison in four species including humans. Implant Dent 4 (1995) 235
36. Boyce R.W., Paddock C.L., Gleason J.R., et al. The effects of risedronate on canine cancellous bone remodeling: Three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res 10 (1995) 211
37. Eriksen E., Axelrod D., and Melsen F. Bone Histomorphometry (1994), Raven Press, New York